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Abstract
Background—Research is needed to improve care and diminish suffering for children with life-
limiting illnesses and their parents. However, there are doubts about whether it is possible to 
conduct paediatric end of life research safely and ethically, as it may unduly burden or 
inadvertently harm participants.
Aim—To compare and evaluate responses from participants to the assessments of burdens and 
benefits that were conducted at two timepoints during a phenomenological study that investigated 
parents’ experiences of having a child with life-limiting cancer participate in a Phase I clinical 
trial.
Discussion—Parents reported that participating in the study was beneficial and resulted in 
minimal burden or distress. The assessment of benefits and burdens at the first timepoint appeared 
sufficient to understand participants’ experiences.
Conclusion—This study adds to the evidence that research may be safely and effectively 
conducted with parents of children who are deceased or have life-limiting illnesses. Further 
research is needed to evaluate the most effective timing of assessments of the burdens and benefits 
of their participation in research.
Implications for practice—It is important when conducting research with people with life-
limiting illnesses or their family members to assess the burdens and benefits of their participation, 
to understand their experiences and assist in its conduct.
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Introduction
A life-limiting illness is a condition for which there is no cure and that is expected to cause 
the patient’s premature death. The death of a child can cause their parents, siblings, extended 
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families, peers and healthcare providers significant physical, psychological, social and 
spiritual pain (Akard et al 2013). Research into palliative and end of life care that considers 
the experiences of patients and their families, including bereavement, has become a global 
priority (Sigma Theta Tau International 2005, Kaasa 2008, Higginson 2016, Clark et al 
2018). Children with life-limiting illnesses and their parents must participate in such 
research, to identify problems accurately, highlight how these can be addressed and 
ultimately improve outcomes.
There are doubts about whether it is possible to conduct research ethically and safely with 
children with life-limiting illnesses and their parents, as it may cause additional burden or 
even inadvertent harm (Hinds et al 2007, Akard et al 2014, Bloomer et al 2017). Children 
and those who are terminally ill are considered vulnerable populations (Shivayogi 2013); 
bereaved parents who cope with intense grief are also vulnerable, although they are not 
usually regarded as a vulnerable population (Shivayogi 2013, Akard et al 2014). Obtaining 
ethical approval for studies involving children with life-limiting illnesses and their parents 
can be challenging, as approval boards may assume that research would worsen the 
participants’ already tenuous circumstances (Hynson et al 2006). ‘Gatekeepers’, such as 
family carers, healthcare providers and approval boards, can deny researchers access to 
individuals they deem vulnerable (Juritzen et al 2011, Cook 2012, Crocker et al 2015, 
Bloomer et al 2017).
Assessing the burdens and benefits to children with life-limiting illnesses of participating in 
research captures their experiences and allows those participants who suffer harm or distress 
to be referred for further support (Hinds et al 2007, Bloomer et al 2017). However, it is 
unclear when to do this. Hinds et al (2007) proposed a research strategy for paediatric 
oncology end of life studies that included follow-up calls to assess participants’ experiences; 
other studies conducted assessments immediately after completing other activities, such as 
data collection (Olcese and Mack 2012, Wiener et al 2015, Allen and Kelley 2016, Aoun et 
al 2017). The authors’ search of the literature found nothing comparing the effectiveness of 
these two strategies.
The authors conducted a phenomenological study of parents’ experiences of having children 
with life-limiting cancer participate in a Phase I clinical trial (Crane et al 2018). This study 
assessed the burdens and benefits of participating in the trial, to ensure parents were not 
unduly psychologically distressed by sharing their experiences. The authors conducted these 
assessments twice: once after collecting data from the participants (timepoint one) and again 
seven to ten days later in a follow-up call (timepoint two).
The purpose of this paper is to compare the participants’ responses at both timepoints and 
compare the values of the two assessments.
Methods
Primary study results and further details of the study’s methods are published elsewhere 
(Crane et al 2018).
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Recruitment
Eligibility criteria for the study included:
• Parents had to be 18 or more years old.
• Parents had to be children’s primary caregivers.
• Parents had to speak English fluently.
• Children had to be enrolled in at least one paediatric oncology Phase I clinical 
trial in the US.
• Children had to be younger than 18 during the trial.
• Children had to have left the Phase I trial at least 60 days before the study, to 
ensure that the off-study transition was fully experienced.
Parents were ineligible for the study if the child had died within the previous 60 days.
A pilot interview was conducted before the main study with a volunteer parent, who was 
recruited based on knowledge of the parent’s advocacy efforts. The main study recruited 
participants from two children’s hospitals and parent advocacy groups between March and 
December 2016. Parents of children attending the hospitals were identified from clinical trial 
records and sent letters by the hospitals containing details of the study and instructions for 
opting in or out; parents who did not respond were contacted two weeks later by phone. 
Parent advocacy group leaders were contacted by email and asked to share recruitment 
materials with group members; interested parents then contacted the authors.
Procedures
If parents met the eligibility requirements, they were asked to complete an electronic form 
confirming their agreement to participate and collecting their demographic data. They then 
took part in an unstructured telephone interview lasting approximately one hour, in which 
they were asked to share the entire story of their children’s participation in Phase I trials; the 
depth of the discussion was then enhanced by using further probing questions, such as ‘Tell 
me more about that’ or ‘What did that mean to you?’
At the end of the interview (timepoint one), participants completed an assessment of the 
study’s burdens and benefits using the modified Pessin et al (2008) instrument, and were 
asked if they had any additional information or concerns to share. Parents whose child had 
died were then offered local bereavement services. A pre-determined safety plan was in 
place for distressed participants.
Seven to 14 days after the interview (timepoint two) [Q1: In Introduction it says seven to 10 
days. Which is correct?], participants were contacted for a follow-up call. This was 
conducted by a research assistant unknown to the participant using a modified version of 
Pessin et al’s (2008) instrument and Hinds et al’s (2007) research strategy. The protocol 
included two attempts at calls at various times of the day, at least three days apart. Only one 
voice message was left with the first call attempt. Participants were asked:
• To share their overall impression of the primary interview.
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• If they wanted to share any additional or clarifying information.
• To complete another assessment of the study’s burdens and benefits using the 
modified Pessin et al (2008) instrument.
• If the follow-up telephone call was appreciated and, if so, why?
• If the follow-up telephone call was difficult or inconvenient and, if so, why?
All interviews and follow-up calls were recorded, transcribed by an independent, third-party 
professional, and verified for accuracy by the second author.
Modified Pessin et al (2008) instrument
The modified version of Pessin et al’s (2008) instrument consisted of two questions, one 
asking if participation in the study was burdensome, the other if it was beneficial (Akard et 
al 2014). Answers were scored on a five-point Likert scale, with options ranging from ‘not at 
all’ (zero) to ‘very much’ (four). Participants who responded that participation was more 
than ‘a little bit’ burdensome or beneficial were asked a closed, multiple-choice follow-up 
question to clarify why participation was burdensome or beneficial.
The original instrument was modified for this study from the original by omitting the options 
in the follow-up question that did not apply to parents of children with life-limiting illnesses 
or to the study design. For example, the original instrument had several inapplicable reasons 
why participation was burdensome (‘I was too weak or too ill at times’ and ‘it interfered 
with other activities that I wanted to do’) or beneficial (‘I enjoyed having the company’ and 
‘it helped pass the time/kept my mind busy’).
Results
Recruitment
In total, 11 parents were recruited to the study, not including the pilot participant who did 
not complete any assessments of burden or benefit. The participants were six of the 17 
parents (35%) approached at the first children’s hospital, three of the nine parents (33%) 
approached at the second children’s hospital and both of the two eligible parents found 
through parent advocacy groups.
Most were female (n=9, 82%); 10 (91%) specified they were white, while one did not state 
their ethnicity. The mean age of their children at the time of enrolment in the first Phase I 
trial was 12.2 years old (SD 4.9 years; range: three to 17 years old) and the mean number of 
children in the household was 1.5 (SD 1.9; range: zero to six). Most parents (n=8, 73%) held 
a college or professional degree or higher. Eight parents (73%) were bereaved.
One parent failed to complete the interview, resulting in a 91% retention rate. No parents 
reported significant distress from participating in the study and the safety plan was not 
implemented for any participants. No parent reported at either of the two timepoints any 
burden resulting from participation.
Hopper and Crane Page 4
Nurse Res. Author manuscript; available in PMC 2020 February 10.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Timepoint one
At the first timepoint, parents reported a median benefit of participation as ‘quite a bit’ 
(median=3, mean=2.6). The most frequently selected reasons on the modified Pessin et al 
(2008) instrument for this were:
• ‘It was helpful or a relief to talk about this issue with someone’ (n=9, 90%).
• ‘It made me feel good to help others/contribute to society’ (n=6, 60%).
• ‘It helped me think about these topics’ (n=5, 50%).
Timepoint two
At the second timepoint, only one (10%) of the parents responded to the first call attempt; a 
voice message was left for the remaining nine parents. A second phone call was made 
between three and ten days after the attempt, to which two parents responded, for a total of 
three parents (30%) completing the second assessment of burdens and benefits.
Two of the three responding parents were bereaved. No parents shared new information 
about their experiences of when their child was in a Phase I trial. One parent was asked to 
clarify details shared in the interview – for example, to describe more fully their experience 
when their child was rejected from participating in a Phase I trial at a distant hospital. Only 
one parent changed an answer they had given to the modified Pessin et al (2008) instrument 
at the first timepoint – they decreased the benefit of participation from ‘quite a bit’ to 
‘somewhat’ (Table 1).
The parental feedback regarding the need for the follow-up call was mixed.
• Parent 1: they did ‘see the need for follow-up phone calls… unless there are 
remaining questions’ and that it was inconvenient ‘having to carve out time’ for 
the follow-up call.
• Parent 2: the follow-up call ‘was appreciated’ and not inconvenient.
• Parent 3: reported being ‘neutral’ regarding the need for the follow-up call and 
that it was not inconvenient.
Discussion
It is important when conducting research with individuals with life-limiting illnesses or their 
family members to assess the burdens and benefits of participation, to understand their 
experiences and assist the conduct of the study. This study reinforces that participation in 
such research by parents of children who are deceased or have life-limiting illnesses causes 
them minimal or no burden or distress and is personally meaningful to them (Hinds et al 
2007, Olcese and Mack 2012, Akard et al 2013, Wiener et al 2015, Allen and Kelley 2016, 
Weaver et al 2018). It also shows that negative psychological reactions from participating in 
research are uncommon and generally mild in severity for these parents, so research can be 
safely and effectively carried out with them (Dyregrov 2004, Hinds et al 2007). Parents who 
participate in end of life research with their children do so out of altruism, for autonomy and 
to optimise care (Kavanaugh and Campbell 2014). Benefits include a sense of 
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empowerment, time to reflect on their experiences and the opportunity to find meaning 
(Gysels et al 2012, Kavanaugh and Campbell 2014, Aoun et al 2017).
This paper evaluated the use of assessments of burden and benefit when conducting end of 
life research with parents of children with cancer. The assessment of benefit and burdens at 
the end of the interview appeared sufficient to understand participants’ experiences during 
the study, the follow-up calls seven to 14 days later providing no additional information. 
However, the generalisability of these results is limited because of the very low response rate 
(n=3, 30%) to the follow-up calls. It is difficult to interpret this lack of response by the other 
participants, but the authors hypothesise that it primarily indicates a lack of interest or time 
to respond; bereavement processes could also have affected parents’ responsiveness.
There are implications for researchers and participants to including a follow-up call in a 
protocol for conducting end of life research with children and parents. These include:
• Additional logistics.
• Increased costs from hiring a research assistant and a transcription service to 
complete, transcribe, verify and evaluate the follow-up calls.
• Greater time required of participants and researchers.
The lack of value added by the follow-up calls in this study leads the authors to hypothesise 
that it is possible to evaluate the burden and benefits of participation in a study sufficiently 
following collection of the data without a subsequent follow-up phone call.
Limitations
The primary limitation of this study was the very small sample, which represented a 
relatively homogeneous population. This significantly decreases the generalisability of the 
results.
It is also likely there was a bias created by respondents self-selecting during recruitment – 
for example, similar participants might respond similarly to the follow-up call attempts.
A further remaining question is whether the frequency or timings of the follow-up calls 
cased the low response rate. Hinds et al (2007) reported a rate of more than 75%, for 
example, but did not disclose the protocol used to achieve this.
Further research
Further research with larger, more diverse samples is warranted. It is also needed to clarify 
the most effective timing and frequency for conducting follow-up calls, given that each time 
a participant is contacted it is an additional burden that must be considered.
Conclusions
This study adds to the evidence that research may be safely and effectively conducted with 
parents of children who are deceased or have life-limiting illnesses. Further research is 
needed to evaluate the most effective timing of assessments of burdens and benefits of 
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participation, including whether these assessments are best conducted at the end of data 
collection – versus in a follow-up phone call – and the most effective timing and frequency 
of follow-up calls.
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Table 1.
Reports of burdens and benefits of participation at the two timepoints
Parent
Timepoint one Timepoint two
Burden Benefit Burden Benefit
1 Not at all Quite a bit Not at all Somewhat
2 Not at all Not at all Not at all Not at all
3 Not at all A little bit Not at all A little bit
Nurse Res. Author manuscript; available in PMC 2020 February 10.
